Fatty acid accumulation
A team of scientists in China have conducted a study to assess the relationship between liver fatty acid accumulation and non-alcoholic fatty liver disease (NAFLD).
A team of scientists in China have conducted a study to assess the relationship between liver fatty acid accumulation and non-alcoholic fatty liver disease (NAFLD).1 NAFLD is one of the most frequent causes of abnormal liver function. As fatty acids can damage biological membranes, fatty acid accumulation in the liver may be partially responsible for the functional and morphological changes that are observed in non-alcoholic liver disease.
The team used an experimental mouse model of NALFD induced by high-fat feed and CCI4 and gas chromatography–mass spectrometry was used to evaluate the fatty acid composition. C57BL/6J mice were given high-fat feed for six weeks to develop NAFLD. They were also given injections of a 40% CCI4-vegetable oil mixture twice a week.
After the six weeks were over it was concluded that NAFLD had developed in the C57BL/6J mice. High-fat feed and CCI4 led to significant increases in C14:0, C16:0, C18:0 and C20:3 (P
The team concluded that the data was consistent with the hypothesis that fatty acids are deranged in mice with non-alcoholic fatty liver injury induced by high-fat feed and CCI4.
1. Xiuying Zhang et al., Lipids in Health and Disease, 2011, 10: 234
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
